Post-Injection Sciatic Nerve Injury (PISNI) Post-Injection Sciatic Nerve Injury, Pediatric Neurology, Faradic Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Physiotherapy, Sciatic Nerve Regeneration, Nerve Conduction Studies, Pediatric Rehabilitation, Functional Mobility Recovery.
Conditions
Interventions
TENS + standard physiotherapy,Faradic Nerve Stimulation (FNS) + standard physiotherapy
Active Comparator Device,Experimental Device
Sponsors
None listed
Eligibility
Sex/Gender
All
Age
3 Years to 19 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria 1. Age: Pediatric patients between 3-19 years, targeting a population at greater risk for nerve injury from injections, as highlighted in recent studies focusing on pediatric sciatic nerve injuries and their management (World Health, 2013), (Hasiba-Pappas et al., 2023, Costello et al., 2023). 2. Diagnosis: Patients with confirmed post-injection sciatic nerve injury (PISNI) through clinical examination and nerve conduction studies (Costello et al., 2023). 3. Consent: Informed consent from a parent or guardian and assent from the child, in line with ethical standards.
Exclusion criteria
Exclusion criteria: 1. Neurotmesis: Severe cases of post-injection sciatic nerve injury where the nerve is completely severed. Surgical interventions, such as neurolysis, are considered more effective in such cases, particularly when performed early. 2. Pre-existing Neurological Disorders: Patients with conditions such as congenital neuropathies, myopathies, cerebral palsy, delayed milestones, syndromic presentations, or neural arch defects that could alter response to nerve stimulation. 3. Skin Conditions: Patients with skin disorders or open wounds at electrode application sites to prevent interference with therapy and minimize risk of adverse events.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain At Baseline, 8 & 16 weeks Wong Baker Scale,Pain At Baseline, 8 & 16 weeks Face, Legs, Activity, Cry, Consolability scale (FLACC Scale),Functional Disability At Baseline, 8 & 16 weeks Pediatric Evaluation of Disability Inventory (PEDI) | — |
Secondary
| Measure | Time frame |
|---|---|
| Nerve Conduction Study At Baseline, 8 & 16 weeks Nerve Conduction Study Test,Social, Psychological & Financial Impact At Baseline, 8 & 16 weeks Pediatric Quality of Life Family Impact Module (PQL-FIM) | — |
Countries
Pakistan
Contacts
Public ContactChaman Lal
Lincoln University College (LUC) Malaysia
Outcome results
None listed